Prostate SBRT with the Raypilot® System
Deliver prostate SBRT with confidence and accuracy. Evidence, engineering, treatment data, and implementation resources for the clinical team.
Evidence & Practice
Explore clinical evidence and real-world outcomes.
Technical Validation
Discover the precision engineering behind the Raypilot System.
Treatment Pathway
See how SBRT compares as a first-line option.
Health Economics
Learn what the transition to SBRT means for your clinic.
Knowledge
News, publications, events, and clinical materials. Everything you need in one place.
Latest News
Recent announcements and updates from Micropos Medical.
Publications
Peer-reviewed studies and clinical posters with summaries: what the study shows, why it matters, and what it means for clinical practice.
Events
Conferences, workshops, and webinars. Past and upcoming.
Videos
Product demos, clinical interviews, and treatment workflow films.
Downloads
Download brochures, specification sheets, and clinical summaries.
Instructions for Use (IFU)
Official IFU documents for The Raypilot System, available in multiple languages.
Investors
Micropos Medical is a Swedish medical device company that develops, manufactures, and sells technology enabling enhanced radiotherapy cancer treatment.
Press Releases
Company news, regulatory updates, and financial announcements.
Financial Reports
Annual reports, interim reports, and year-end reports.
Financial Calendar
Scheduled dates for reports and investor events.
Corporate Governance
Board of Directors and IR contact.
May 7, 2024
Välkommen att ladda ner Årsredovisning 2023.
Share news
May 4, 2026
Styrelsen i Micropos Medical AB (“Micropos” eller “Bolaget”) har tidigare fattat beslut om att med stöd av det bemyndigande som lämnades på årsstämman den 21 maj 2025 att genomföra en företrädesemission av aktier om 25 MSEK före avdrag för transaktionskostnader(“Företrädesemissionen”). Här kan du läsa all information om…
April 20, 2026
Styrelsen i Micropos Medical AB (“Micropos” eller “Bolaget”) har idag fattat beslut om attmed stöd av det bemyndigande som lämnades på årsstämman den 21 maj 2025 att genomföraen företrädesemission av aktier om 25 MSEK före avdrag för transaktionskostnader(“Företrädesemissionen”). Ladda ner all information här…
KALLELSE TILL ÅRSSTÄMMA I MICROPOS MEDICAL AB (PUBL) Aktieägarna i Micropos Medical AB (publ), 556648-2310, kallas härmed till årsstämma torsdagen den 21 maj 2026 kl. 16.30, på Hotel Waterfront Adolf Edelsvärds Gata 10, Göteborg. Inregistrering till stämman börjar kl. 16.00. Rätt att delta och anmälan Rätt att delta i…
February 4, 2026
We are proud to announce that Micropos Medical AB has received the MDR as well as the UKCA certificate for the Raypilot System. This certification confirms that Micropos Medical’s Raypilot System is now fully compliant with the European Union’s regulation MDR 2017/745 and UK MDR 2002 for medical devices.The new regulations…
December 8, 2025
Former chief physicist Jan Lindström has worked with radiation since 1988. After reviewing a large number of scientific studies, he argues that it is unethical for healthcare not to apply Augmented SBRT with the Raypilot® System in the treatment of prostate cancer.
November 5, 2025
With an almost full house on Monday evening, around 60 curious participants gathered to learn about the latest developments in radiation therapy and advances in the treatment of prostate cancer. The evening featured insightful presentations by Jan Lindström, former hospital physicist at Karolinska, Thomas Lindström from Micropos Medical, and Kai…
Welcome to follow us for news, insights, and updates.